Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man
- PMID: 9952
- PMCID: PMC1402643
- DOI: 10.1111/j.1365-2125.1975.tb00564.x
Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man
Abstract
Cimetidine, a new H2-receptor antagonist, was safely administered to eighteen healthy man by the intravenous, intraduodenal or oral route. 2 When gastric secretion was maximally stimulated by either histamine or pentagastrin, the simultaneous administration of cimetidine produced marked inhibition of both acid and pepsin secretion. 3 Cimetidine was well absorbed by mouth and had a blood half-life of 2 hours. 4 Cimetidine was rapidly excreted via the kidneys and about 70% of the excreted material was unchanged drug. 5 Clinical evaluation of cimetidine in patients with peptic ulceration is recommended.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
